[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Achives
 
Powered by Google
 

 Public Hearing: Use of Color on Pharmaceutical
Product Labels, Labeling and Packaging

March 7, 2005, NIH Campus, Bethesda, MD.  

The agenda for the Part 15 Hearing on Use of Color on Pharmaceutical Labeling and Packaging is below. The meeting is scheduled to be held on March 7 from 8 am – 2 pm. It will be held at the Lister Hill Auditorium on the NIH Campus in Bethesda Maryland. Please note that parking is scarce on the NIH campus and that strict security procedures are in place. It is recommended that speakers/observers take the Metro to the Hearing, if possible.

The FDA expert panel will consist of:

Dr. Paul Seligman, (Director, Office of Pharmacoepidemiology and Statistical Science, CDER)
Dr. Robert Meyer (Director, Office of Drug Evaluation II, CDER )
Dr. Wiley Chambers, (Deputy Director, Division of Anti-Inflammatory, Analgesic and Ophthalmic Drug Products, CDER )
Dr. Peter Carstensen, (Senior Systems Engineer, Division of Device User Programs and Systems Analysis, CDRH)
Ms. Carol Holquist, Director, Division of Medication Error Prevention and Technical Support, CDER)

Agenda

8:00 – Dr. Paul Seligman - Welcome
8:10 – Carol Holquist –Use of Color on Pharmaceutical Labeling and Packaging – an Overview
8:20 – Mr. Charles Meyers - American Society of Health Systems Pharmacists
8:50 – Dr. Mary Baker, Dr. Thomas Willer - Hospira, Inc
9:30 – Dr. Eric Sheinin – United States Pharmacopeia
10:00 – Break
10:30 – Dr. Michael Cohen – Institute for Safe Medication Practices
11:00 – Dr. Mary Ann McElligott - Novo Nordisk
11:45 – Dr. Joseph Cranston – American Medical Association
12:15 – Dr. James Broselow
12:45 – Dr. Frank Kyle – American Dental Association
1:15 – Dr. Allan Jensen – American Academy of Ophthalmology
1:45 – Dr. Paul Seligman - Closing Remarks

Transcript

Presentations

  •  
  • Use of Color on Pharmaceutical Product Labels, Labeling and Packaging, Mary Baker,
  • The Broselow-Luten System, James Broselow, MD [PPT]
  • Managing pharmaceutical package labels with color to reduce medication errors, Michael R. Cohen, Institute for Safe Medication Practices (ISMP) [PDF]
  • A Uniform Color-Coding System for Topical Ocular Medicine, Allan Jensen, MD, American Academy of Ophthalmology
  • Local Anesthetic Color Code, Frank Kyle, American Dental Association [PPT]
  • Use of Color on Pharmaceutical Product Labels, Labeling and Packaging, Mary Ann McElligott, Ph.D., Novo Nordisk [PPT]
  • Use of Color on Pharmaceutical Packaging and Labeling, Eric B. Sheinin, Ph.D., USP [PPT]
  • Pharm.D., MBA, Thomas Willer, Ph.D, Hospira. [PPT]

For further information, contact Mary Gross at GrossM@cder.fda.gov.

PDF requires the free Adobe Acrobat Reader
 

Back to Top     Back to Workshops

Date created: February 28, 2005, updated October 14, 2005

horizonal rule